Quiet Therapeutics is a cancer drug discovery and development company that is creating a new generation of cancer therapeutics utilizing its proprietary GAGomer technology to specifically target tumor cells.

The GAGomer therapeutic nanoparticles have the ability to target certain types of cancers that express a biomarker. Once the nanoparticles target the specific cancer cells, they deliver a therapeutic payload that leads to the death of the cancer cells.

This new class of cancer treatment enables the flexibility of delivering a medicine that can kill the cancer cells, block the production of proteins that promote the cancer, or even use the cancer cells own machinery to produce proteins that kill the cancer cells.

Quiet Therapeutics develops a diverse set of DNA, RNA, and small molecule anticancer therapeutics.